Treatment of Calcium Oxalate Nephrolithiasis

Initial Non-Pharmacologic Management

The American College of Physicians recommends that all patients with calcium oxalate stones should first increase fluid intake to achieve at least 2 liters of urine output daily, and if this fails to prevent recurrence, initiate pharmacologic monotherapy with thiazide diuretics, potassium citrate, or allopurinol based on metabolic profile 1
Increase water intake to produce at least 2 liters of urine output per 24 hours, which reduces stone recurrence by approximately 55% (relative risk 0.45, 95% CI 0.24-0.84) 2, 1, 3
Maintain normal dietary calcium intake of 1,000-1,200 mg per day—do NOT restrict calcium, as calcium restriction paradoxically increases urinary oxalate and stone risk 3
Limit sodium intake to 2,300 mg daily to reduce urinary calcium excretion 3
Reduce non-dairy animal protein to 5-7 servings of meat, fish, or poultry per week, as animal protein generates sulfuric acid, increasing urinary calcium and reducing citrate 3
Limit high-oxalate foods (nuts, chocolate, tea, spinach, wheat bran) particularly in patients with hyperoxaluria 3
Avoid sugar-sweetened beverages, especially colas acidified with phosphoric acid (relative risk 0.83 for recurrence) 3, 4

The American College of Physicians recommends pharmacologic monotherapy when increased fluid intake alone fails to prevent stone formation, choosing one agent based on metabolic abnormalities 1
Thiazide diuretics are indicated for patients with high or relatively high urinary calcium, reducing composite stone recurrence from 48.5% to 24.9% 3, 2
Potassium citrate is indicated for patients with low or relatively low urinary citrate (target >320 mg/day), reducing composite stone recurrence from 52.3% to 11.1% 3, 2
Allopurinol is indicated for patients with recurrent calcium oxalate stones who have hyperuricosuria and normal urinary calcium, reducing composite stone recurrence from 55.4% to 33.3% 3, 2

Obtain 24-hour urine collection to assess volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium, and creatinine, and repeat at 6 months after initiating therapy to assess response 3, 5

Never restrict dietary calcium—this increases urinary oxalate and stone risk 3
Avoid calcium supplements unless specifically indicated; prefer dietary calcium sources consumed with meals to bind oxalate 3
Do not use sodium-based alkali (sodium citrate/bicarbonate) instead of potassium citrate 5
Do not use combination therapy as first-line—monotherapy is equally effective with fewer side effects 1
Do not ignore vitamin C supplements—vitamin C metabolizes to oxalate and increases stone risk at doses >1000 mg/day 3

The American College of Physicians provides moderate-strength evidence that thiazide diuretics reduce composite stone recurrence risk by 48% (RR 0.52, 95% CI 0.39-0.69) compared to placebo or control in patients with multiple past calcium stones 6, 7
Hydrochlorothiazide is highly effective for preventing recurrent calcium oxalate stones in patients with multiple prior stones, reducing stone recurrence by approximately 48% (from 48.5% to 24.9%) 6, 7

Hydrochlorothiazide is most appropriate for patients with multiple recurrent calcium oxalate stones who have failed conservative management with increased fluid intake 6, 7

Maintain normal dietary calcium intake (1,000-1,200 mg/day) to maximize the hypocalciuric effect and limit potassium wasting 8
Reduce non-dairy animal protein to 5-7 servings weekly to reduce stone risk 8

Potassium citrate shows even greater efficacy (RR 0.25, reducing recurrence from 52.3% to 11.1%), but is specifically indicated for hypocitraturia 6, 7
Allopurinol reduces recurrence (RR 0.59) but benefits are limited to patients with hyperuricosuria or hyperuricemia 6, 7
Combination therapy (thiazide + citrate or thiazide + allopurinol) offers no additional benefit over monotherapy and increases side effects and withdrawal rates 6, 7